McCarter & English, LLP
Dihydropyrrolopyridine inhibitors of ROR-gamma
Provided are novel compounds of Formula (I): pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of diseases and disorders mediated by RORγ. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I) and methods for their use in treating one or more inflammatory, metabolic, autoimmune and other diseases or disorders. 
Vitae Pharmaceuticals, LLC
C
C07D
inventional
Stephen D. Wei David A. Colin M. Suresh B. Jing Linghang Yi Lawrence Wayne Andrew Chengguo
Lotesta Zhao Claremon Tice Singh Yuan Zhuang Fan Dillard Marcus Dong